Bio-Rad Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	7,876	8,178	9,202	9,208	12,445	22,616
Market Cap Growth	17.16%	-11.13%	-0.07%	-26.01%	-44.97%	30.00%
Enterprise Value	7,690	7,985	8,869	8,960	12,000	21,927
Last Close Price	294.32	302.99	328.51	322.89	420.49	755.57
PE Ratio	47.16	10.88	-	-	-	5.37
Forward PE	32.81	28.94	28.85	26.51	28.66	59.87
PEG Ratio	-	2.21	2.21	2.21	2.21	2.21
PS Ratio	3.04	3.17	3.59	3.45	4.44	7.74
PB Ratio	1.15	1.10	1.40	1.05	1.29	1.65
P/TBV Ratio	1.16	1.11	1.41	1.08	1.30	1.67
P/FCF Ratio	22.05	21.83	31.77	42.20	152.51	42.22
P/OCF Ratio	15.43	15.37	20.22	24.56	64.02	33.78
EV/Sales Ratio	2.97	3.09	3.46	3.35	4.28	7.50
EV/EBITDA Ratio	17.29	37.56	21.09	18.52	24.86	43.82
EV/EBIT Ratio	27.80	169.16	32.97	26.53	24.86	43.82
EV/FCF Ratio	21.53	21.31	30.63	41.06	147.06	40.93
Debt / Equity Ratio	0.14	0.18	0.20	0.16	0.14	0.01
Debt / EBITDA Ratio	13.99	6.51	3.27	2.91	2.88	0.45
Debt / FCF Ratio	3.86	3.70	4.75	6.44	17.01	0.42
Net Debt / Equity Ratio	-0.03	-0.02	-0.04	-0.02	-0.04	-0.05
Net Debt / EBITDA Ratio	-1.89	-0.73	-0.69	-0.43	-0.85	-1.30
Net Debt / FCF Ratio	-0.52	-0.42	-1.00	-0.95	-5.00	-1.22
Asset Turnover	0.25	0.26	0.24	0.21	0.18	0.19
Inventory Turnover	1.65	1.66	1.54	1.66	1.91	2.15
Quick Ratio	2.17	3.87	4.53	4.02	4.03	1.91
Current Ratio	3.21	5.62	6.48	5.83	5.55	2.92
Return on Equity (ROE)	2.36%	10.84%	-24.09%	-6.94%	-31.14%	36.11%
Return on Assets (ROA)	0.43%	0.36%	1.96%	1.96%	2.38%	2.54%
Return on Invested Capital (ROIC)	0.52%	0.45%	2.37%	2.33%	2.67%	2.78%
Return on Capital Employed (ROCE)	0.61%	0.50%	2.60%	2.73%	3.21%	3.40%
Earnings Yield	2.14%	9.19%	-	-	-	18.64%
FCF Yield	4.54%	4.58%	3.15%	2.37%	0.66%	2.37%
Buyback Yield / Dilution	3.69%	3.31%	3.41%	1.93%	1.40%	-0.16%
Total Shareholder Return	3.69%	3.31%	3.41%	1.93%	1.40%	-0.16%

SEC Filings: 10-K · 10-Q